FDA Approvals of Aging Therapies Have Started: The Motivation for, Status of, & Path to Eliminating Aging

In this webinar, Karl R. Pfleger, PhD (AgingBiotech.info) joins in for a data-driven overview of where the field stands, which mechanisms are advancing, and what approvals to expect over the next five years.

The session will outline the current approved interventions, the regulatory review pipeline, the phase 3 landscape, and the commercial and regulatory factors shaping near-term outcomes.

Who Should Attend

This session is intended for biotech and pharmaceutical R&D leaders, investors, clinical researchers, and drug discovery scientists interested in the regulatory status and commercial trajectory of therapeutics targeting core aging biology.

Collaborative Drug Discovery - CDD Vault (CDD) is an OBIO® member.